Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.

Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.

http://www.wikidata.org/entity/Q36422777

about

Targeting cancer stem cells by using the nanoparticles Targeting TGF-β signaling in cancer High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients Biology of transforming growth factor beta in hepatocarcinogenesis.Novel therapeutic strategies for targeting liver cancer stem cells.Regulation of TGF-β1-Induced Pro-Apoptotic Signaling by Growth Factor Receptors and Extracellular Matrix Receptor Integrins in the Liver.EPMA position paper in cancer: current overview and future perspectives.Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.The rationale for targeting TGF-β in chronic liver diseases.A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.TGF-β1-induced expression of Id-1 is associated with tumor progression in gastric cancer.HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.Cytokines are associated with postembolization fever and survival in hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization.Transforming growth factor-beta 1-induced apoptosis is blocked by beta 1-integrin-mediated mitogen-activated protein kinase activation in human hepatoma cells.Possible contribution of circulating transforming growth factor-beta1 to immunity and prognosis in unresectable hepatocellular carcinoma.Galectin-1 Controls the Proliferation and Migration of Liver Sinusoidal Endothelial Cells and Their Interaction With Hepatocarcinoma Cells.

P2860

Q26783590-1B6BBD62-FB5E-481B-A362-7426DC842BD9 Q27012443-CA78080A-F5C4-4BEF-9A15-8A775D77FA70 Q33798379-6512DBAD-25D9-4355-AB2B-CBC78D1711A5 Q34136515-5EE9BD17-9EF8-47F0-B9AA-93BB3B4F2AC3 Q34940971-3C0D0D32-4708-4604-91D0-1565164AAE43 Q35427394-EFDA200F-EDEA-4C0E-8F8F-666E683BB4DD Q35532215-69880155-2DE7-4812-B704-41C2096BC92D Q37527686-769311B6-B881-4F00-BE35-EA9D5F4CBFD4 Q38715538-18E3BCE6-B1E8-40C9-ABF8-B64F3D0B3391 Q38764893-8D21E48D-56B0-4710-B653-60176192C806 Q38991532-DF799421-0574-48E6-AFA4-CDBC20CF7CAC Q39550377-2103B63E-AB31-46B0-9376-405E2C78D7F9 Q40242952-DC177B5A-0F03-4D72-A17E-A38437B74546 Q45152340-3434D517-9E3C-4046-BF85-4C0F4F651000 Q47722253-38B80770-EA79-4D2C-9A1D-597A2FDEEEC0 Q53284113-79E8FB04-FFFF-44C8-94B5-8490DB0E4BDF

P2860

Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.

http://www.wikidata.org/entity/Q36422777

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh

1997年學術文章

@zh-hant

name

Elevated urinary transforming ...... otic hepatocellular carcinoma.

@ast

Elevated urinary transforming ...... otic hepatocellular carcinoma.

@en

type

label

Elevated urinary transforming ...... otic hepatocellular carcinoma.

@ast

Elevated urinary transforming ...... otic hepatocellular carcinoma.

@en

prefLabel

Elevated urinary transforming ...... otic hepatocellular carcinoma.

@ast

Elevated urinary transforming ...... otic hepatocellular carcinoma.

@en

P1433

Q36422777-3DE38A84-7045-42FA-8386-965732BC6ED9

P1476

Q36422777-E07B985A-43CA-4EDE-9A56-83BBA7906685

P2093

Q36422777-007B42CD-0681-4B91-A33B-7F8534ECDC53

Q36422777-082976F1-01E2-41E4-A398-F3E24401719D

Q36422777-2F03325E-7F02-4144-AC4D-F20789E24D79

Q36422777-34C652D3-D01B-48FF-A667-BE1F4D32E02E

Q36422777-3C24F3A6-41C6-4C80-80EF-247EC07B871C

Q36422777-60232FFB-920E-464F-8686-4A2CED7C559C

Q36422777-A1C1E292-C99B-4198-A852-9FE100A25C4C

Q36422777-ADAD720F-52CE-40BD-95F1-2532BFD23D5B

Q36422777-C3B3B641-7B0E-42ED-8BD9-0559C70B6189

P2860

Q36422777-06A035BE-0FDF-4702-8088-64835168A75E

Q36422777-082DC1DB-A762-4368-9A5C-5C8B826E02A4

Q36422777-2FFBED4C-E35E-4BFD-A22F-9EA5F3A59337

Q36422777-3A9EF202-EA3F-4249-A1AE-49A3C2BD3475

Q36422777-40899C80-6BFE-4FCE-8946-AF76112DE527

Q36422777-5129BCAD-B9E8-42FF-ACEC-49DEA8629438

Q36422777-52EF7D0C-7011-41C7-B8F3-C3DD2BA0B400

Q36422777-5DF8B7FD-9D0F-4A7C-A8DB-8D95B35D4E83

Q36422777-66109396-F59C-4D82-8F6C-B8D97A54CB88

Q36422777-82C807F0-998D-4CCB-9B7A-FEAB859016B7

P2888

Q36422777-EFC241CB-5B01-4A47-AA84-B56AFB2DB58F

P304

Q36422777-8554D13E-96AB-4564-A8AC-135E377325DA

P31

Q36422777-72E92144-7E1E-4ED1-8EEA-E66D03B778B4

P356

Q36422777-19B8387C-863E-4C9A-9EB6-FAACFD97B56C

P407

Q36422777-2E38593F-B556-4929-80D7-D47013EF2CA6

P433

Q36422777-A30E873F-35EF-471C-AF0A-2AA5177EAB58

P478

Q36422777-95F12B35-AFE8-4710-9726-2AEFB7C25A4F

P577

Q36422777-3571F635-6171-4DEB-9579-BB6C8D2FB5E5

P5875

Q36422777-2916EE71-E20D-4D9F-8B8D-0A7B0746CFD4

P698

Q36422777-E5A6C07A-4857-47E2-8A72-848F738AAE44

P921

Q36422777-FCB233CE-0F9A-41C3-B23A-E6ECCD8841E1

P932

Q36422777-1F64A2D9-0F7A-4880-8A68-EC5D91E7C156

P356

P1433

British Journal of Cancer

P1476

Elevated urinary transforming ...... otic hepatocellular carcinoma.

@en

P2093

Chang WY

http://www.w3.org/2001/XMLSchema#string

Chuang LY

http://www.w3.org/2001/XMLSchema#string

Ho MS

http://www.w3.org/2001/XMLSchema#string

Hsieh MY

http://www.w3.org/2001/XMLSchema#string

Jeng JE

http://www.w3.org/2001/XMLSchema#string

Lin ZY

http://www.w3.org/2001/XMLSchema#string

Tsai JF

http://www.w3.org/2001/XMLSchema#string

Tsai JH

http://www.w3.org/2001/XMLSchema#string

Yang ML

http://www.w3.org/2001/XMLSchema#string

P2860

Measuring the accuracy of diagnostic systems

Transection of the oesophagus for bleeding oesophageal varices.

Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma

Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.

Transforming growth factor-beta: possible roles in carcinogenesis.

Transforming growth factor beta 1 differentially regulates alpha-fetoprotein and albumin in HuH-7 human hepatoma cells.

Epidermal growth factor-related transforming growth factors in the urine of patients with hepatocellular carcinoma.

High level of beta-type transforming growth factor activity in human urine obtained from cancer patients.

Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan.

Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan.

P2888

P304

244-250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1997.369

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13987603

http://www.w3.org/2001/XMLSchema#string

P698

9231926

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

2223945

http://www.w3.org/2001/XMLSchema#string